E2F-3 (PG30) Antibody sc-56665 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemE2F-3 (PG30) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-56665
Antibody TypePrimary Antibodies
NCBI Gene AliasesE2F-3, E2f3a, E2F3b
ClonePG30
Quantity200 µg/ml
ApplicationsWB, IP
Reactivitymouse, rat, human
ClonalityMonoclonal
Conjugate/TagUnconjugated
Hostmouse
FormatPurified
NCBI Full Gene NameE2F transcription factor 3
TargetE2F-3
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) APC/C prevents non-canonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrestbioRxivNovember 14, 2023Brandon L Mouery, Eliyambuya M Baker, Christine A Mills, Laura E Herring, Dalia Fleifel, Jeanette Gowen CookCell Signaling Technology; BSA), E2F2 (1:1000; rabbit; A3297; Abclonal; milk), E2F3 (1:1000; mouse; sc-56665; Santa Cruz Biotechnology; milk), Skp2 (1:1000; rabbit; 4313; Cell Signaling Technology; milk), p27

(2) Involvement of miRNA-34a regulated Krüppel-like factor 4 expression in hyperoxia-induced senescence in lung epithelial cellsRespiratory researchDecember 10, 2022Maeda H, Yao H, Go H, Huntington KE, De Paepe ME, Dennery PA.p16 (ab108349, Abcam), MDM4 (ab222905, Abcam or sc-74468, Santa Cruz), E2F1 (ab137415, Abcam), E2F3 (sc-56665, Santa Cruz), CCND1 (ab134175, Abcam), KLF4 (ab129473, Abcam), β-actin (ab8227, Abcam) and calnexin

(3) Understanding of cell death induced by the constituents of Taxus yunnanensis woodScientific reportsApril 15, 2022Akao Y, Terazawa R, Sugito N, Heishima K, Morikawa K, Ito Y, Narui R, Hamaguchi R, Nobukawa T.(#JM-3330-100) and caspase-8 (#M032-3; MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., Tokyo, JP); anti-E2F3 (SC-56665; Santa Cruz Biotechnology, Santa Cruz, CA, USA); and anti-SIRT1 and anti-Ras antibodies (ab32441; Abcam,

(4) Excessive E2F Transcription in Single Cancer Cells Precludes Transient Cell Cycle Exit after DNA DamageSSRN Electronic JournalApril 1, 2022Hendrika A. Segeren, Lotte van Rijnberk, Eva Moreno, Frank Riemers, Ruixue Yuan, Richard Wubbolts, Alain de Bruin, Bart WestendorpCell Signaling Technology Cat# 2360; RRID: AB_2080320 Mouse monoclonal anti-E2F3 (PG30) Santa Cruz Biotechnology Cat# sc-56665; RRID: AB_1122397 Mouse monoclonal anti-Emi1 (FBXO5) Thermo Fisher Cat# 37-6600; RRID: AB_2533333 Goat

(5) Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3International journal of molecular sciencesOctober 10, 2021Park MC, Kim H, Choi H, Chang MS, Lee SK.blocked and probed with the following antibodies: mouse anti-E2F3 (1:500; Santa Cruz Biotechnology, SC-56665) and rabbit anti-β-actin (1:2000; Cell Signaling Technology, #4970S). Bound antibodies were detected

(6) Knockdown SNHG20 Suppresses Nonsmall Cell Lung Cancer Development by Repressing Proliferation, Migration and Invasion, and Inducing Apoptosis by Regulating miR-2467-3p/E2F3Cancer biotherapy & radiopharmaceuticalsMay 1, 2021Chen H, Tan X, Ding Y.

(7) Excessive E2F Transcription in Single Cancer Cells Precludes Transient Cell-Cycle Exit after DNA DamageCell reportsDecember 1, 2020Segeren HA, van Rijnberk LM, Moreno E, Riemers FM, van Liere EA, Yuan R, Wubbolts R, de Bruin A, Westendorp B.

(8) Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cellsMolecular medicine reportsOctober 1, 2020Gao C, Liu SG, Lu WT, Yue ZX, Zhao XX, Xing TY, Chen ZP, Zheng HY, Li ZG.antibodies against CREBBP (cat. no. sc-369; 1:500; Santa Cruz Biotechnology, Inc.) and E2F3 (cat. no. sc-56665; 1:500; Santa Cruz Biotechnology, Inc.) overnight at 4°C. Following the primary incubation, cells were

(9) Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expressionThe international journal of biochemistry & cell biologyOctober 1, 2020Li S, Zeng M, Yang L, Tan J, Yang J, Guan H, Kuang M, Li J.

(10) Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3BeLifeSeptember 28, 2020Roelofs PA, Goh CY, Chua BH, Jarvis MC, Stewart TA, McCann JL, McDougle RM, Carpenter MA, Martens JW, Span PN, et al.Santa Cruz Cat#:sc-251 RRID:AB_627476 WB (1:1,000) Antibody Anti-E2F3 (mouse monoclonal) Santa Cruz Cat#:sc-56665 RRID:AB_1122397 WB (1:800) Antibody Anti-E2F5 (mouse monoclonal) Santa Cruz Cat#:sc-374268 RRID:AB_10988935 WB

(11) The RIP140 gene is a transcriptional target of E2F1PloS oneJanuary 1, 2012Docquier A, Augereau P, Lapierre M, Harmand PO, Badia E, Annicotte JS, Fajas L, Cavaillès V.SDS–PAGE. Western blotting detection was performed using primary antibodies against E2Fs (sc-251, sc-9967, sc-56665, sc-1082 for E2F1, 2, 3, 4 respectively and sc-53642 for DP1 from Santa-Cruz Biotechnology). To check

(12) CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genesEMBO reportsJanuary 1, 0001"Chirackal Manavalan AP, Pilarova K, Kluge M, Bartholomeeusen K, Rajecky M, Oppelt J, Khirsariya P, Paruch K, Krejci L, Friedel CC, et al."(H2A),,ab18255,–,–,"1:10,000",Abcam ORC6,3A4,sc‐32735,–,–,"1:3,000",Santa Cruz E2F1,,A300‐766A,5 μg,–,–,Bethyl E2F3,PG30,sc‐56665,5 μg,–,–,Santa Cruz CDK12,U1‐4th immune,–,–,–,"1:3,000",In‐house made CDK12,R‐12,sc‐81834,–,2 μg,1:500,Santa Cruz

Be the First to Write a Review!

E2F-3 (PG30) Antibody

E2F-3 (PG30) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (12)

Reviews

E2F-3 (PG30) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map